# Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Source: https://onco.cc/trials/nct04138719/  
OnCo record `nct04138719` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of nab-paclitaxel, carboplatin and epirubicin in triple-negative breast cancer, run by Hebei Medical University Fourth Hospital, now recruiting.

## Summary

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer is a phase 2, randomised interventional study registered as NCT04138719 by Hebei Medical University Fourth Hospital, with a registry enrolment figure of 520 participants, started 2019-11-20 and due to reach its primary completion in 2026-10-20. Interventions recorded: Nab-paclitaxel + Carboplatin; Nab-paclitaxel + Epirubicin. Conditions listed: Breast Cancer; Triple-negative Breast Cancer; Nab-paclitaxel. Triple-negative eligibility wording from the registry: "Histologically confirmed triple negative breast cancer;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT04138719
- Phase: 2
- Setting: Clinical Study of Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
- Sponsor: Hebei Medical University Fourth Hospital
- Enrolled: 520

## Sources

- ClinicalTrials.gov NCT04138719: https://clinicaltrials.gov/study/NCT04138719

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Epirubicin](https://onco.cc/drugs/epirubicin/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct04138719.json